The largest database of trusted experimental protocols

Rotor gene q 5plex hrm instrument

Manufactured by Qiagen
Sourced in Germany

The Rotor-Gene Q 5plex HRM instrument is a real-time PCR cycler that can perform high-resolution melt (HRM) analysis. It has a 5-channel detection system and can accommodate 72 samples in a rotor format. The instrument is capable of detecting multiple targets simultaneously.

Automatically generated - may contain errors

11 protocols using rotor gene q 5plex hrm instrument

1

Lung Adenocarcinoma Plasma Mutation Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Written informed consent was obtained from all patients under a protocol approved by the Institutional Review Board of the University of Maryland, Baltimore. The project identification code is 27681. The protocol was approved on 25 August 2006. Plasma samples were obtained from 25 patients who were diagnosed with lung adenocarcinoma. EDTA-anticoagulant blood samples were collected at the time of the interview by venipuncture from the consented subjects as previously described [11 (link)]. The samples were centrifuged at 750× g for 10 min, and the plasma fractions were stored at −80 °C [11 (link)]. We also obtained plasma samples of three NSCLC patients from Tissue Solutions (Glasgow, UK). EGFR mutations of the lung cancer patients were determined in their tumor tissues by the Qiagen RGQ PCR with the Rotor-Gene® Q 5plex HRM® instrument (Qiagen) in clinical laboratories. Plasma samples collected from 20 age- and gender-matched cancer-free smokers were used as controls to determine the cut-off level of mutation allele frequency.
+ Open protocol
+ Expand
2

SARS-CoV-2 Viral Nucleic Acid Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A viral nucleic acid isolation kit (Biospeedy-Turkey) was used to isolate SARS-CoV-2 from oro-nasopharyngeal swab and tracheal aspirate samples. In accordance with the manufacturer’s recommendations (Biospeedy-Turkey), a sample of 10 µl (final volume) was used. Amplification was performed on the Qiagen Rotor-Gene Q 5plex HRM instrument (Qiagen, Germany).
+ Open protocol
+ Expand
3

Quantitative Analysis of Gene Expression in Rabies Virus Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reverse transcription-quantitative real-time PCR (RT-qPCR) was carried out on a Rotor-Gene Q 5plex HRM instrument (Qiagen, Hilden, Germany) with EvaGreen fluorescence dye (Biotium, Hayward, USA) to monitor cDNA amplification of GNAI2, AKT3, IL21, and GAPDH through increased fluorescence intensity. The specificity of the amplified products was checked by melting curve analysis, and the expected size of the fragments was further visualized by gel electrophoresis (2% agarose) and staining with GelRed (Biotium, Hayward, CA). Results were confirmed by triplicate testing. Relative mRNA expression was calculated using the delta–delta Ct method (Livak and Schmittgen, 2001 (link)). Sequences were analyzed using Seqscanner. Statistical analysis was performed by depicting an error bar for each gene in each condition to compare relative expression of the abovementioned genes in uninfected and RABV-infected states.
+ Open protocol
+ Expand
4

Quantitative DNA Detection by λ Exonuclease

Check if the same lab product or an alternative is used in the 5 most similar protocols
To a 200 μl PCR tube, 39 μl of water, 5 μl of 10 × ThermolPol Reaction Buffer, 2 μl of probe (10 pmol) and 1 μl of target ssDNA (5 pmol) were added and mixed well. The solution was heated to 85°C and then gradually cooled down to 37°C. Then 3 μl of λ exo (1.67 U) was added and the detection was performed at 37°C on a Rotor-Gene Q 5plex HRM Instrument (QIAGEN, Hilden, Germany) with gain level of 8. Fluorescence intensity was measured once a cycle (5 s per cycle) for 240 cycles. The excitation and emission wavelengths were set to 470 and 510 nm, respectively. The rate of fluorescence increase was determined by the slope of the linear portion of the time curve.
+ Open protocol
+ Expand
5

SARS-CoV-2 Detection from Clinical Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
A viral nucleic acid isolation kit was used to isolate SARS-CoV-2 from oro-nasopharyngeal swab and tracheal aspirate (TA) samples. In accordance with the manufacturer's recommendations (Biospeedy-Turkey), a sample of 10 μL (final volume) was used. RT-PCR kit (Biospeedy-Turkey) targeting N and ORF1ab genes of SARS-Cov 2 was used. Amplification was performed on the Qiagen Rotor-Gene Q 5plex HRM instrument (Qiagen, Germany).
+ Open protocol
+ Expand
6

SARS-CoV-2 Detection from Clinical Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
A viral nucleic acid isolation kit (Bioeksen, Turkey) was used for the isolation of SARS-CoV-2 from oro-nasopharyngeal swab and tracheal aspirate (TA) samples. In accordance with the recommendations of the manufacturer, a sample of 10 μL (final volume) was used. RT-PCR kit (Bioeksen, Turkey) targeting N and ORF1ab genes of SARS-CoV-2 was used. Amplification was performed on the Qiagen Rotor-Gene Q 5plex HRM instrument (Qiagen, Hilden, Germany).
+ Open protocol
+ Expand
7

Quantitative Fluorescence Detection Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To a 200 μl PCR tube, 39 μl of water, 5 μl of 10 × ThermolPol Reaction Buffer, 2 μl of probe (10 pmol) and 1 μl of the complementary strand (5 pmol) were added and mixed well. The solution was heated to 85°C and then gradually cooled down to 37°C. Then, 3 μl of λ exo (NEB) was added, and the detection was performed at 37°C on a Rotor-Gene Q 5plex HRM Instrument (QIAGEN, Hilden, Germany). The amount of λ exo as trimer was 0.53 pmol (2.5 U, final concentration 10.6 nM) for Figures 1A and 3, Supplementary Figure S2, S3, S4 and S6A, 0.36 pmol (1.7 U, final concentration 7.2 nM) for Figure 2, Supplementary Figure S5 and S6B, and 0.18 pmol (0.83 U, final concentration 3.6 nM) for Figure 5, Supplementary Figure S7 and S8B. Fluorescence intensity was measured once per cycle (5 s per cycle). The excitation and emission wavelengths were set at 470 and 510 nm, respectively, for the probes labeled with FAM and 585 and 610 nm, respectively, for the probes labeled with ROX. The rate of fluorescence increase was determined by the slope of the linear portion of the time curve. All experiments were repeated at least three times.
+ Open protocol
+ Expand
8

EGFR Mutation Detection in Cytological Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
For EGFR mutation detection, the Rotor-Gene Q 5plex HRM instrument was used with the therascreen EGFR RGQ PCR kit (therascreen EGFR assay; Qiagen, Inc.). This assay is approved for use in the United States, Europe, Japan, and China, and the kit is based on the amplification-refractory mutation system (ARMS) and Scorpion PCR technology, which enable the sensitive and selective site-specific detection of 29 types of somatic mutations in EGFR (24 (link)). The reaction conditions were as follows: 95°C for 15 min for 1 cycle; 95°C for 30 sec and 60°C for 60 sec for 40 cycles. The analysis was performed using the Rotor-Gene Q series software, version 2.0.2 (Qiagen, Inc.). For comparison between the three types of cytological samples (cell pellets, cell-free supernatants and FFPE cell blocks) using cell lines, the cycle quantification (Cq) value of the mutant allele in each sample was compared using the therascreen EGFR ‘Deletions’ assay, which detects EGFR E746_A750del. For the validation study comparing BLF specimens to FFPE tissue specimens, the manufacturer-supplied cut-off delta Cq (ΔCq) values were used to determine the result whether positive or negative for the mutation in each EGFR mutation reaction.
+ Open protocol
+ Expand
9

Sensitive EGFR Mutation Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The EGFR mutation analysis was performed from July 2015 to June 2017 using the therascreen EGFR RGQ PCR Kit (Qiagen). The therascreen EGFR RGQ PCR Kit is a molecular diagnostic kit for detecting specific mutations, insertions, and deletions in the EGFR gene using realtime PCR on the Rotor-Gene Q 5plex HRM instrument (Qiagen). The kit includes all necessary reagents optimized for rapid and sensitive detection of a low percentage of mutant DNA in a background of wild-type genomic DNA. The kit provides exceptionally high sensitivity and specificity for the detection of specific mutations. This technique allows the detection of tumor cells as little as 1% of a mixture of tumor cells with normal tissue. The procedure and interpretation of results are performed per the user's manual provided by Qiagen without any modification. Idylla (Biocartis) was used to confirm the results to rule out false positivity. Idylla EGFR mutation test is a fully automated molecular diagnostic kit.
+ Open protocol
+ Expand
10

Qualitative IDH1/2 Mutation Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
IDH1/2 mutations was detected using ARMS PCR using IDH1/2 RGQ PCR kit following manufacturer's instructions (Qiagen). Qualitative detection of 6 mutations within IDH1 codon 132, one within IDH1 codon 100 (R100Q) and 5 within IDH2 codon 172 was noted. PCR was performed using the Rotor-Gene Q 5-plex HRM instrument (Qiagen). The PCR condition used was: 95°C Time: 10 min Cycling 40 times 95°C for 15 sec 60°C for 60 sec with an acquisition of FAM ™ fluorescence in channel Green: Single. Sample ΔCt values were calculated as the difference between the mutation assay Ct and respective total assay Ct from the same sample. Samples were classified as mutation positive if the ΔCt value was less than or equal to the ΔCt cut-off value of the respective mutation assay [10] .
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!